YOLFTbeta
Sanigen Co. Ltd

Sanigen Co. Ltd

188260 · KQ · Healthcare / Biotechnology

1,883.00KRW-15.00 (-0.79%)

Price History

Full chart

Market Stats

Previous Close1,898.00
Open1,823.00
Day Range1,823.00 – 1,929.00
52-Week Range1,341.00 – 2,890.00
Volume18.11K
Market Cap29.13B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.47
50-Day Avg2,022.62
200-Day Avg1,913.71

About

Sanigen Co. Ltd, a food sanitation and safety specialist, develops and services solutions for safe food manufacturing, distribution, and sales in Korea and internationally. The company offers PCR detection and nucleic acid extraction kits; bag, diluent, beam template, macroswab, and squeeze products; pathogen detection NGS panel kits; and hand sanitizers, vomit clean up kits, and pure systems. It also provides Microbial, physicochemical analysis, and food sanitation/lab services. Sanigen Co. Ltd was founded in 2005 and is headquartered in Anyang-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Park Jeong Woong
  • Employees0
  • HeadquartersPyeongchon Digital Empire Building 411, Anyang-si, South Korea, 14059, Korea
  • Websitehttps://www.sanigen.kr

Leadership

  • Mr. Park Jeong WoongChairman & CEO · b. 1969
  • Mr. Gyeong-il JeonSales Director & Director · b. 1977

Financials

Income Statement

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue25.22B26.76B22.27B24.01B15.35B
Growth (%)-+6.09%-16.78%+7.82%-36.05%
Cost of Revenue21.61B22.86B19.23B20.82B12.24B
Gross Profit3.62B3.90B3.04B3.19B3.11B
Gross Margin14.33%14.56%13.65%13.30%20.25%
Operating Expense6.48B7.97B9.36B8.30B7.48B
Operating Income-2.87B-4.08B-6.32B-5.10B-4.37B
Operating Margin-11.36%-15.24%-28.36%-21.26%-28.49%
EBITDA--1.84B-7.91B-5.39B-4.75B
EBITDA Margin--6.88%-35.51%-22.43%-30.94%
Net Income-4.28B-4.06B-8.78B-5.07B-5.82B
Net Income Margin-16.97%-15.19%-39.41%-21.12%-37.91%
R&D1.59B1.69B2.29B2.09B1.92B
R&D as % of Total Revenue6.31%6.32%10.30%8.69%12.48%
Interest Expense907.81M1.41B437.28M206.98M146.94M
Interest Expense % of Total Revenue3.60%5.28%1.96%0.86%0.96%

Balance Sheet

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.34B15.63B21.45B16.64B10.11B
Total Liabilities26.51B28.56B7.58B6.45B7.64B
Total Equity-9.17B-12.92B13.87B10.20B2.48B
Cash9.77B356.30K188.45K275.24K1.58B
Net Debt--979.91M-881.50M

Cash Flow

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.59B-3.21B-3.78B-5.44B-4.18B
Investing Cash Flow--3.56B1.03B9.37B-
Financing Cash Flow-539.21M1.67B-878.23M-
Capital Expenditure422.99M3.48B273.64M333.22M210.88M
Free Cash Flow-3.01B-6.69B-4.05B-5.77B-4.39B
FCF to OCF116.34%208.33%107.25%106.13%105.05%

Key Statistics & Ratios

Market Cap29.13B
Enterprise Value20.26B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.05
Price / Book2.65
Revenue (TTM)14.21B
Gross Profit (TTM)3.19B
EBITDA-2.17B
Profit Margin-27.44%
Operating Margin-10.63%
Return on Equity-39.26%
Return on Assets-10.16%
Shares Outstanding13.77M
Shares Float3.52M
Beta0.47
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%